07 Nov 2014

Stilnoct (Zolpidem) - United Kingdom

ATC: N05CF
NERVOUS SYSTEM
PSYCHOLEPTICS
HYPNOTICS AND SEDATIVES
BENZODIAZEPINE RELATED DRUGS
Stilnoct

Last Updated on 07 Nov 2014 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Stilnoct Indication

The short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.

 

Stilnoct Generic Name

Zolpidem

Type

POM

Summary Product Characteristics (SPCs) Links
All SPC - Stilnoct (external site)
SPC - Stilnoct 5mg Film-Coated Tablets (external site)
SPC - Stilnoct 10mg Film-Coated Tablets (external site)

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Selected content related to Stilnoct (Zolpidem)

Clinical Trials

Journals

  • Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.1
    Randall S, Roehrs TA, Roth T.
    Sleep. 2012 Nov 1;35(11):1551-7. doi: 10.5665/sleep.2208.

    Study Objectives: To evaluate the long-term (8 months) efficacy of zolpidem in adults with chronic primary insomnia using polysomnography.
    Conclusions: In adults with primary insomnia, nightly zolpidem administration remained efficacious across 8 months of nightly use.
    Read full Article
     
  • Zolpidem use and risk of fracture in elderly insomnia patients.2
    Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, Park BJ.
    J Prev Med Public Health. 2012 Jul;45(4):219-26. doi: 10.3961/jpmph.2012.45.4.219. Epub 2012 Jul 31.

    Objectives: To evaluate the risk of fractures related with zolpidem in elderly insomnia patients.
    Conclusions: Zolpidem could increase the risk of fracture in elderly insomnia patients. Therefore zolpidem should be prescribed carefully and the elderly should be provided with sufficient patient education.
    Read full Article

Guidelines

Overview of Disease

"Insomnia is defined as difficulty initiating sleep, maintaining sleep, waking too early or nonrestorative sleep despite adequate opportunity and circumstances for sleep. The sleep disturbances associated with insomnia can result in daytime impairments and/or distress."1

References

  1. Randall S, Roehrs TA, Roth T. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep. 2012 Nov 1;35(11):1551-7. doi: 10.5665/sleep.2208.
  2. Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, Park BJ. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health. 2012 Jul;45(4):219-26. doi: 10.3961/jpmph.2012.45.4.219. Epub 2012 Jul 31.

Stilnoct Marketing Information

Stilnoct Generic Name
Zolpidem
Marketing Company
Sanofi-aventis
Drug Type
POM
Date of Issue, Marketing Authority
  • Stilnoct 5mg Film-Coated Tablets: 03/12/2009
     
  • Stilnoct 10mg Film-Coated Tablets: 27/01/2009

Related Drugs - Sleep Medicine

Back to top